Post-Authorization Active Surveillance Safety Study Using Secondary Data to Monitor Real-World Safety of Spikevax in Europe (COVID-19)First published 25/11/2021 Last updated 23/02/2024 EU PAS number: EUPAS44273StudyOngoing